A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)
Status:
Completed
Trial end date:
2014-11-29
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to determine whether the test product and the reference
product are bioequivalent based on the pharmacokinetics after administration of ug/kg as a
single intravenous dose and as a single subcutaneous dose of each of the formulations. The
study is consisted of randomization, 2 parts, 4 treatments, 2 way cross over.